Dr. Pasquale Benedetto highlighted the rarity and complexity of sarcomas, stressing the need for multidisciplinary care and genomic testing due to diverse histologies. Chemo response varies; doxorubicin and paclitaxel help select cases. Immunotherapy benefits 20%, especially with complex karyotypes.